{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:12:41Z","timestamp":1787069561185,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41401-022-00899-2","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:36:33Z","timestamp":1648629393000},"page":"2542-2549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGF\u03b21 signaling pathway"],"prefix":"10.1038","volume":"43","author":[{"given":"Shuai-xing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-nan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-dan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"899_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118:1021\u201340.","journal-title":"Circ Res"},{"key":"899_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71:549\u201374.","journal-title":"Cell Mol Life Sci"},{"key":"899_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1172\/JCI31044","volume":"117","author":"BC Berk","year":"2007","unstructured":"Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest. 2007;117:568\u201375.","journal-title":"J Clin Invest"},{"key":"899_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013;10:15\u201326.","journal-title":"Nat Rev Cardiol"},{"key":"899_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2741\/e484","volume":"4","author":"Y Fu","year":"2012","unstructured":"Fu Y, Xiao H, Zhang Y. Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling. Front Biosci (Elite Ed). 2012;4:1625\u201337.","journal-title":"Front Biosci (Elite Ed)"},{"key":"899_CR6","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","volume":"107","author":"IS Anand","year":"2003","unstructured":"Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003;107:1278\u201383.","journal-title":"Circulation."},{"key":"899_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/j.1552-4604.1991.tb03715.x","volume":"31","author":"R Dixon","year":"1991","unstructured":"Dixon R, Gourzis J, McDermott D, Fujitaki J, Dewland P, Gruber H. AICA-riboside: safety, tolerance, and pharmacokinetics of a novel adenosine-regulating agent. J Clin Pharmacol. 1991;31:342\u20137.","journal-title":"J Clin Pharmacol"},{"key":"899_CR8","doi-asserted-by":"publisher","first-page":"e32115","DOI":"10.1371\/journal.pone.0032115","volume":"7","author":"Y Sun","year":"2012","unstructured":"Sun Y, Lian Z, Jiang C, Wang Y, Zhu H. Beneficial metabolic effects of 2\u2019,3\u2019,5\u2019-tri-acetyl-N6-(3-hydroxylaniline) adenosine in the liver and plasma of hyperlipidemic hamsters. PLoS One. 2012;7:e32115.","journal-title":"PLoS One"},{"key":"899_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1476-511X-10-67","volume":"10","author":"Z Lian","year":"2011","unstructured":"Lian Z, Li Y, Gao J, Qu K, Li J, Hao L, et al. A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells. Lipids Health Dis. 2011;10:67.","journal-title":"Lipids Health Dis"},{"key":"899_CR10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1194\/jlr.M054742","volume":"56","author":"L Huang","year":"2015","unstructured":"Huang L, Fan B, Ma A, Shaul PW, Zhu H. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice. J Lipid Res. 2015;56:986\u201397.","journal-title":"J Lipid Res"},{"key":"899_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.08.012","volume":"85","author":"B Chen","year":"2016","unstructured":"Chen B, Li J, Zhu H. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A\/NF-\u03baB\/LOX-1 pathway. Vasc Pharmacol. 2016;85:1\u201310.","journal-title":"Vasc Pharmacol"},{"key":"899_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2019.02.045","volume":"852","author":"MJ Wang","year":"2019","unstructured":"Wang MJ, Peng XY, Lian ZQ, Zhu HB. The cordycepin derivative IMM-H007 improves endothelial dysfunction by suppressing vascular inflammation and promoting AMPK-dependent eNOS activation in high-fat diet-fed ApoE knockout mice. Eur J Pharmacol. 2019;852:167\u201378.","journal-title":"Eur J Pharmacol"},{"key":"899_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2337\/diabetes.55.04.06.db05-1178","volume":"55","author":"B Guigas","year":"2006","unstructured":"Guigas B, Bertrand L, Taleux N, Foretz M, Wiernsperger N, Vertommen D, et al. 5-Aminoimidazole-4-carboxamide-1-\u03b2-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes. 2006;55:865\u201374.","journal-title":"Diabetes."},{"key":"899_CR14","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI40671","volume":"120","author":"M Foretz","year":"2010","unstructured":"Foretz M, H\u00e9brard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010;120:2355\u201369.","journal-title":"J Clin Invest"},{"key":"899_CR15","doi-asserted-by":"publisher","unstructured":"Mia MM, Cibi DM, Ghani SA, Singh A, Tee N, Sivakumar V, et al. Loss of Yap\/Taz in cardiac fibroblasts attenuates adverse remodeling and improves cardiac function. Cardiovasc Res. 2021. https:\/\/doi.org\/10.1093\/cvr\/cvab205.","DOI":"10.1093\/cvr\/cvab205"},{"key":"899_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/eurheartj\/ehx261","volume":"39","author":"H Xiao","year":"2018","unstructured":"Xiao H, Li H, Wang JJ, Zhang JS, Shen J, An XB, et al. IL-18 cleavage triggers cardiac inflammation and fibrosis upon \u03b2-adrenergic insult. Eur Heart J. 2018;39:60\u20139.","journal-title":"Eur Heart J"},{"key":"899_CR17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00109-015-1309-8","volume":"93","author":"D Wu","year":"2015","unstructured":"Wu D, Lei H, Wang JY, Zhang CL, Feng H, Fu FY, et al. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation. J Mol Med. 2015;93:1311\u201325.","journal-title":"J Mol Med"},{"key":"899_CR18","doi-asserted-by":"publisher","first-page":"10461","DOI":"10.1074\/jbc.M800902200","volume":"283","author":"R Mishra","year":"2008","unstructured":"Mishra R, Cool BL, Laderoute KR, Foretz M, Viollet B, Simonson MS. AMP-activated protein kinase inhibits transforming growth factor-\u03b2-induced Smad3-dependent transcription and myofibroblast transdifferentiation. J Biol Chem. 2008;283:10461\u20139.","journal-title":"J Biol Chem"},{"key":"899_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/ATVBAHA.107.156687","volume":"28","author":"K Fujita","year":"2008","unstructured":"Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, et al. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-\u03b1. Arterioscler Thromb Vasc Biol. 2008;28:863\u201370.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"899_CR20","doi-asserted-by":"publisher","first-page":"172442","DOI":"10.1016\/j.ejphar.2019.172442","volume":"857","author":"W Ge","year":"2019","unstructured":"Ge W, Zhang W, Gao R, Li B, Zhu H, Wang J. IMM-H007 improves heart function via reducing cardiac fibrosis. Eur J Pharmacol. 2019;857:172442.","journal-title":"Eur J Pharmacol"},{"key":"899_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep28597","volume":"6","author":"H Xiao","year":"2016","unstructured":"Xiao H, Zhang J, Xu Z, Feng Y, Zhang M, Liu J, et al. Metformin is a novel suppressor for transforming growth factor (TGF)-\u03b21. Sci Rep. 2016;6:28597.","journal-title":"Sci Rep"},{"key":"899_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/1440-1681.12748","volume":"44","author":"Y Feng","year":"2017","unstructured":"Feng Y, Wang S, Zhang Y, Xiao H. Metformin attenuates renal fibrosis in both AMPK\u03b12-dependent and independent manners. Clin Exp Pharmacol Physiol. 2017;44:648\u201355.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"899_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cvr\/cvq066","volume":"87","author":"H Xiao","year":"2010","unstructured":"Xiao H, Ma X, Feng W, Fu Y, Lu Z, Xu M, et al. Metformin attenuates cardiac fibrosis by inhibiting the TGF\u03b21\u2013Smad3 signalling pathway. Cardiovasc Res. 2010;87:504\u201313.","journal-title":"Cardiovasc Res"},{"key":"899_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1165\/rcmb.2012-0244OC","volume":"49","author":"CC Lin","year":"2013","unstructured":"Lin CC, Yeh HH, Huang WL, Yan JJ, Lai WW, Su WP, et al. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. Am J Respir Cell Mol Biol. 2013;49:241\u201350.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"899_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1074\/jbc.271.2.611","volume":"271","author":"D Stapleton","year":"1996","unstructured":"Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem. 1996;271:611\u20134.","journal-title":"J Biol Chem"},{"key":"899_CR26","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/jcmm.13978","volume":"23","author":"S Qiu","year":"2019","unstructured":"Qiu S, Liu T, Piao C, Wang Y, Wang K, Zhou Y, et al. AMPK\u03b12 knockout enhances tumour inflammation through exacerbated liver injury and energy deprivation-associated AMPK\u03b11 activation. J Cell Mol Med. 2019;23:1687\u201397.","journal-title":"J Cell Mol Med"},{"key":"899_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2014.04.018","volume":"74","author":"G Noppe","year":"2014","unstructured":"Noppe G, Dufeys C, Buchlin P, Marquet N, Castanares-Zapatero D, Balteau M, et al. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPK\u03b11. J Mol Cell Cardiol. 2014;74:32\u201343.","journal-title":"J Mol Cell Cardiol"},{"key":"899_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00395-021-00846-y","volume":"116","author":"C Dufeys","year":"2021","unstructured":"Dufeys C, Daskalopoulos EP, Castanares-Zapatero D, Conway SJ, Ginion A, Bouzin C, et al. AMPK\u03b11 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism. Basic Res Cardiol. 2021;116:10.","journal-title":"Basic Res Cardiol"},{"key":"899_CR29","first-page":"57","volume":"60","author":"M Duvnjak","year":"2009","unstructured":"Duvnjak M, Tomasic V, Gomercic M, Smircic Duvnjak L, Barsic N, Lerotic I. Therapy of nonalcoholic fatty liver disease: current status. J Physiol Pharmacol. 2009;60:57\u201366.","journal-title":"J Physiol Pharmacol"},{"key":"899_CR30","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","volume":"13","author":"EP Bottinger","year":"2002","unstructured":"Bottinger EP, Bitzer M. TGF-\u03b2 signaling in renal disease. J Am Soc Nephrol. 2002;13:2600\u201310.","journal-title":"J Am Soc Nephrol"},{"key":"899_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-physiol-012110-142225","volume":"73","author":"HA Chapman","year":"2011","unstructured":"Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol. 2011;73:413\u201335.","journal-title":"Annu Rev Physiol"},{"key":"899_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-\u03b2 family signalling. Nature. 2003;425:577\u201384.","journal-title":"Nature."}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00899-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T22:05:42Z","timestamp":1664575542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00899-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1038\/s41401-022-00899-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"13 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}